• Doxepin, Urine
  • Ewing Sarcoma (EWSR1/FLI1 and EWSR1/ERG) by Reverse Transcriptase PCR (RT-PCR), Paraffin
  • HLA B Genotype
  • Coenzyme Q10, Reduced and Total, Plasma
  • Cytochrome P450 3A5 (CYP3A5) Genotyping
  • Glucose, Body Fluid
  • Group A Streptococcus (Streptococcus pyogenes), Culture
  • Anticholinergic poisoning
  • Group B Streptococcus (GBS), Molecular Detection, PCR
  • Maple Syrup Disease Genetic Testing
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Blastomyces Antigen, Quantitative, Bronchoalveolar Lavage
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Blastomyces Antigen, Quantitative, Bronchoalveolar Lavage
Medical Test

Methodology
Access to Blastomyces Antigen, Quantitative, Bronchoalveolar Lavage is restricted.